Buscar
Mostrando ítems 1-1 de 1
Tesis Doctoral
Evaluación del daño vascular tras el tratamiento con Sunitinib: disfunción endotelial y mecanismos patogénicos implicados
(2021-05-11)
Sunitinib (Su) is an orally active multitarget tyrosine kin ase inhibitor with antiangiogenic and antineoplastic effects. Su is the first line choice for metastatic renal cell carcinoma treatment ( and the second line ...